enalapril - Neonatal Disorders

What is Enalapril?

Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure. It works by relaxing blood vessels, making it easier for the heart to pump blood. While it is commonly prescribed for adults, it can also be used in pediatric patients under specific conditions and with careful monitoring.

Indications in Pediatrics

Enalapril is primarily indicated for managing hypertension and heart failure in pediatric patients. It may also be used in cases of chronic kidney disease to reduce proteinuria and slow the progression of renal disease. The drug is beneficial for children with congenital heart defects as it helps to manage symptoms and improve heart function.

Dosage and Administration

The dosage of enalapril in children is generally based on body weight and the specific condition being treated. For hypertension, the initial dose is usually 0.08 mg/kg once daily, which can be adjusted based on clinical response and tolerance. For heart failure, the starting dose is often lower and titrated cautiously. Enalapril is available in oral tablets and liquid forms, making it easier to administer to younger children.

Monitoring and Side Effects

Children on enalapril should be closely monitored for blood pressure, renal function, and electrolyte levels. Common side effects include dizziness, cough, and elevated blood potassium levels (hyperkalemia). Rare but serious side effects include angioedema and significant drops in blood pressure, particularly after the first dose.

Contraindications and Precautions

Enalapril is contraindicated in patients with a history of angioedema related to previous ACE inhibitor therapy. It should be used with caution in children with renal impairment or those taking medications that can increase potassium levels. Pregnant adolescents should avoid enalapril due to the risk of fetal harm.

Drug Interactions

Enalapril may interact with various medications, including diuretics, other antihypertensive agents, and drugs that increase potassium levels, such as potassium supplements or potassium-sparing diuretics. Concurrent use of NSAIDs may reduce the antihypertensive effect of enalapril and worsen renal function.

Special Considerations

Pediatric patients require tailored dosing and careful monitoring when prescribed enalapril. Parents and caregivers should be educated about the importance of adherence to the prescribed regimen and the need for regular follow-up appointments. Any signs of adverse reactions should be promptly reported to the healthcare provider.

Conclusion

Enalapril is a valuable medication in the pediatric population for managing hypertension, heart failure, and certain renal conditions. Proper dosing, monitoring, and awareness of potential side effects and drug interactions are crucial for its safe and effective use in children.



Relevant Publications

Partnered Content Networks

Relevant Topics